The Mounjaro Savings Card — officially called the Mounjaro Savings Program — can bring your out-of-pocket cost down to as little as $25 per 28-day supply if you have eligible commercial or private insurance, or to a fixed monthly cap if you're uninsured. Eligibility depends on your insurance type, and Medicare or Medicaid enrollees do not qualify.
What Is the Mounjaro Savings Card and Who Qualifies?
The Mounjaro Savings Card is a co-pay assistance program run directly by Eli Lilly. When you use it at a participating pharmacy, Lilly covers a portion of what you would otherwise owe after your insurance processes the claim. As of mid-2026, the program terms are:
- Commercially insured patients: Pay as little as $25 per fill for up to 12 fills per calendar year, capped at a maximum Lilly contribution of $150 per fill (terms subject to change — verify at the time of activation).
- Uninsured or cash-pay patients: A separate fixed-price option may apply; Lilly periodically adjusts these terms, so confirm directly with the program.
- Not eligible: Anyone enrolled in Medicare, Medicaid, TRICARE, or any other federal or state government health program.
You must be a U.S. resident and have a valid Mounjaro prescription. The card is not valid where prohibited by law, and Lilly reserves the right to modify or discontinue the program.
Most important: The Mounjaro Savings Card only works with commercial insurance. If you are on Medicare, Medicaid, or any government plan, you are not eligible — and using the card when ineligible is considered insurance fraud. Ask your pharmacist to confirm your eligibility before your first use.
How Do You Activate and Use the Card?
The process is straightforward but requires a few steps before your first fill:
- Get your prescription. Your prescriber sends a Mounjaro prescription to your preferred pharmacy.
- Enroll online or by phone. Visit Lilly's official Mounjaro savings program page or call the number on the card. You'll enter your date of birth, zip code, and confirm you are not a government-insurance enrollee.
- Receive your card or code. You may get a physical card in the mail or a digital card number you can present immediately at the pharmacy.
- Present the card at pick-up. Give both your primary insurance card and the Mounjaro Savings Card to the pharmacist. Your insurance is billed first; the savings card covers the remaining co-pay up to the program limit.
- Renew annually. The card resets each January 1. You typically need to re-enroll or reactivate for a new calendar year.
What Does It Actually Cost Without the Card?
Understanding the list price helps you appreciate how much the card saves — and what you're exposed to if coverage lapses.
| Scenario | Estimated Monthly Cost (2026) |
|---|---|
| List price (no insurance, no card) | ~$1,060–$1,100 per fill |
| Commercial insurance + savings card | As low as $25 per fill |
| Commercial insurance, no savings card | Varies widely; $50–$500+ depending on plan |
| Medicare Part D (no savings card) | Varies; $0–$100+ depending on plan formulary and the $2,000 annual out-of-pocket cap enacted in 2025 |
| Lilly Cares Foundation (uninsured, low income) | Potentially $0 if income-eligible |
A meaningful 2026 development for Medicare enrollees: the Inflation Reduction Act's $2,000 annual out-of-pocket cap on Part D drugs took full effect in 2025, reducing the financial burden for many Medicare patients — even though they still cannot use the savings card.
What If Your Insurance Denies Coverage?
Commercial insurers increasingly cover Mounjaro for its FDA-approved indication of type 2 diabetes management, but coverage for weight loss alone remains inconsistent. If your claim is denied:
- Request a prior authorization (PA). Your prescriber's office can submit clinical documentation supporting medical necessity.
- File an appeal. Insurers are required to have an appeals process. A letter of medical necessity from your doctor strengthens the case.
- Ask about step therapy waivers. Some plans require you to try an older medication first. If you have a documented contraindication, your prescriber can request a waiver.
- Consider Lilly Cares. The Lilly Cares Foundation Patient Assistance Program provides free medication to uninsured or underinsured patients who meet income criteria (generally at or below 400% of the federal poverty level).
- Explore telehealth formularies. Some GLP-1–focused telehealth platforms negotiated fixed cash-pay rates in 2025–2026; these vary and are not affiliated with Lilly's savings program.
How Does Mounjaro's Savings Card Compare to Wegovy and Zepbound?
Each medication has its own manufacturer savings program with different terms:
- Zepbound (tirzepatide for obesity): Also made by Lilly, Zepbound has its own separate savings card — you cannot use the Mounjaro card for a Zepbound prescription or vice versa. Zepbound's program has historically offered similar $25/fill co-pay assistance for eligible commercially insured patients.
- Wegovy (semaglutide for obesity) and Ozempic (semaglutide for type 2 diabetes): Novo Nordisk runs separate savings programs for each. Terms fluctuate; as of early 2026, Wegovy's savings program has faced higher demand and more frequent eligibility adjustments compared to prior years.
- Key distinction: Because Mounjaro is FDA-approved for type 2 diabetes (not obesity), it often faces fewer insurer barriers than Wegovy or Zepbound, which are labeled primarily for weight management.
A noteworthy 2025 clinical development: the SURMOUNT-MMO trial (Bhatt et al., New England Journal of Medicine, 2025) demonstrated that tirzepatide reduced the risk of major adverse cardiovascular events in adults with obesity or overweight. This finding has spurred some insurers to broaden coverage criteria for both Mounjaro and Zepbound — check with your plan directly.
Frequently Asked Questions
This site provides general information only and does not constitute medical advice. All content is sourced to FDA labeling, NIH publications, or peer-reviewed clinical trials. Always consult your prescriber before making any medication decision.